IGF-1 LR3 is a long-acting analog of insulin-like growth factor-1 engineered for advanced research applications focused on cellular growth, tissue development, and anabolic signaling pathways. Its modified structure allows for reduced binding to IGF-binding proteins and extended biological activity, making it particularly valuable in sustained signaling models.
This extended activity enables researchers to study how prolonged IGF signaling may influence cellular proliferation, nutrient partitioning, and tissue regeneration. Its role in growth-related pathways makes it a key compound in research focused on structural development, recovery, and metabolic efficiency.
Manufactured in the United States and verified at ≥99% purity through high performance liquid chromatography (HPLC) and mass spectrometry analysis, each multidose vial is produced to strict research-grade standards for identity, purity, and consistency.
In controlled research environments, IGF-1 LR3 has been studied for its role in supporting cellular growth pathways, enhancing tissue repair signaling, influencing muscle and structural development models, and contributing to broader investigations into anabolic and metabolic regulation.
Key Research Focus Areas:
Quality & Compliance:
Important Notice:
For research purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Scroll for More >>
Made in USA
A modified peptide provided for laboratory research, produced with consistent specifications and supported by analytical testing documentation.
$85.00
